Explore XTL Biopharmaceuticals analyst ratings and price targets (NASDAQ:XTLB) on Benzinga. Stay updated on expert opinions and forecasts for XTLB stock.
There is no price target for XTL Biopharmaceuticals
There is no analyst for XTL Biopharmaceuticals
There is no last upgrade for XTL Biopharmaceuticals
There is no last downgrade for XTL Biopharmaceuticals.
There is no next analyst rating for XTL Biopharmaceuticals.
There is no next analyst rating for XTL Biopharmaceuticals.